JY

The Joint Corp.

JYNTHealthcareNASDAQ

Medical Care Facilities · Last scanned Jul 16, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$54.9M
+5.2% YoY
Net Income
$2.9M
+150.2% YoY
EBITDA
$808,241
-72.1% YoY
Free Cash Flow
$9.3M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11CONFIRMED Above MA150+0.6% from MA150, price crossed above
MACD Positive CrossoverHistogram +0.0018, positive momentum
Jul 10 MACD Positive CrossoverHistogram +0.0050, positive momentum
About The Joint Corp.

The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company carries a $127.3M market cap, placing it firmly in the micro-cap category. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support.

Key stats
Market Cap$127.3M
P/E (TTM)99.22
Fwd P/E20.61
EPS$0.09
Beta1.09
52W Change-22.1%
ROE7.0%
Analysis

The Joint Corp. holds $20.7M in cash against $2.0M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. The company generates $9.3M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 7.0% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 0.6% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $80.0M to $54.9M.

With cash comfortably exceeding debt, JYNT has financial flexibility that may help navigate uncertain periods. The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing JYNT.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms